《业绩》神威药业(02877.HK)首九个月营业额约28.8亿人币 按年跌近17%

阿斯达克财经
08 Nov 2024

神威药业(02877.HK) 公布,截至今年9月底止九个月,营业额为28.87亿元人民币(下同),按年跌16.9%。

过往派息
公布日期派息事项派息内容
2024/08/29第二期中期业绩股息:人民币 0.1100
2024/03/28中期业绩股息:人民币 0.4300
2024/03/28末期业绩无派息
2023/08/30第二期中期业绩股息:人民币 0.1100

期内,注射液产品营业额跌26.7%至10.28亿元;软胶囊产品营业额跌19.3%至3.91亿元;颗粒剂产品营业额减少2.2%至4.57亿元;中药配方颗粒产品营业额跌12%至8.24亿元;其他剂型产品营业额升2.6%至1.87亿元。

今年首九个月,注射液产品、软胶囊产品、颗粒剂产品及中药配方颗粒产品,分别占集团之营业总额约35.6%、13.5%、15.8%及28.5%。(js/w)
(港股报价延迟最少十五分钟。沽空资料截至 2024-11-07 16:25。)
AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10